Addition Of A Mast Cell Stabilizing Compound To Organ Preservation Solutions Decreases Lung Reperfusion Injury
- 31 March 1998
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 115 (3) , 631-637
- https://doi.org/10.1016/s0022-5223(98)70328-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Phenotypic and Quantitative Changes in Mast Cells after Syngeneic Unilateral Lung Transplantation in the RatClinical Science, 1996
- Lung Mast Cells Increase in Number and Degranulate during Pulmonary Artery Occlusion/Reperfusion Injury in DogsAmerican Review of Respiratory Disease, 1993
- Lodoxamide Tromethamine Prevents Neutrophil Accumulation in Reexpansion Pulmonary EdemaJournal of Cardiovascular Pharmacology, 1989
- Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells.Circulation Research, 1988
- Xanthine oxidase inhibition attenuates ischemic-reperfusion lung injuryJournal of Surgical Research, 1988
- Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbitJournal of Vascular Surgery, 1987
- Lung reperfusion in dogs causes bilateral lung injuryJournal of Applied Physiology, 1987
- The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthmaInflammation Research, 1986
- Effects of Lodoxamide on Ischemic Reperfused MyocardiumJournal of Cardiovascular Pharmacology, 1982
- Inhibition of oxidative enzymes by anti-allergy drugsInflammation Research, 1981